The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
Abstract
PURPOSE: Angiogenesis, a process fundamental to tumor growth, is regulated by angiogenic factors. This article reviews prognostic and other clinical implications of circulating angiogenic factors in cancer patients. METHODS: A MEDLINE search of literature was performed using the names of various angiogenic factors as the key words. Studies pertaining to circulating angiogenic factors in cancer patients were reviewed. Pertinent literature regarding tumor expression of common angiogenic factors and their prognostic relevance in human cancers were also examined. RESULTS: A substantial number of studies have demonstrated a strong association between elevated tumor expression of vascular endothelial growth factor (VEGF) and advanced disease or poor prognosis in various cancers. This supports the pivotal role of VEGF in regulating tumor angiogenesis. More recently, there is mounting evidence that the level of circulating VEGF in patients with different types of cancer may be predictive of tumor status and prognosis. Preliminary data also suggest that circulating VEGF may be useful in predicting and monitoring tumor response to anticancer therapies and in follow-up surveillance for tumor relapse. There are reports supporting the prognostic value of other circulating angiogenic factors such as basic fibroblast growth factor, platelet-derived endothelial cell growth factor, transforming growth factor-beta, and angiogenin, but their clinical significance is less conclusive because of limited data. CONCLUSION: Circulating VEGF seems to be a reliable surrogate marker of angiogenic activity and tumor progression in cancer patients. Evaluation of circulating angiogenic factors is a promising novel approach of prognostication in cancer patients that has the advantages of being convenient and noninvasive, and it may provide new prognostic information that is not afforded by conventional clinicopathologic prognostic indicators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Rak, J. W., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., & Kerbel, R. S. (1995) · PubMed · Cited by 762
Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Nature · doi:10.1038/325257a0 · Cited by 754
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 724
Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.663 · Cited by 713
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
Maeda, K., Chung, Y.-S., Ogawa, Y., Kang, S.-M., Ogawa, M., Sawada, T., & Sowa, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960301)77:5<858::aid-cncr8>3.0.co;2-a · Cited by 627
Banks, R., Forbes, M., Kinsey, S., Stanley, A., Ingham, E., Walters, C., & Selby, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.158 · Cited by 599
Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.9.365 · Cited by 596
Florkiewicz, R. Z., & Sommer, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.3978 · Cited by 522
Friess, H., Yamanaka, Y., Büchler, M., Ebert, M., Beger, H. G., Gold, L. I., & Korc, M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91084-u · Cited by 522
Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
Kieser, A., Weich, H. A., Brandner, G., Marmé, D., & Kölch, W. (1994) · PubMed · Cited by 511
Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., & Hanahan, D. (1991) · Cell · doi:10.1016/0092-8674(91)90033-u · Cited by 508
Gasparini, G., Bonoldi, E., Gatti, C., Vinante, O., Toi, M., Tominaga, T., Gion, M., Dittadi, R., Verderio, P., Boracchi, P., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.139 · Cited by 494
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., & Folkman, J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.356 · Cited by 464
Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction
Friesel, R. E., & Maciag, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542215 · Cited by 455
Platelet: transporter of vascular endothelial growth factor.
Verheul, H. M. W., Hoekman, K., Bakker, S., Eekman, C., Folman, C. C., Broxterman, H. J., & Pinedo, H. M. (1997) · PubMed · Cited by 428
Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C. L., Söker, S., Niknejad, K., Peoples, G. E., & Klagsbrun, M. (1995) · PubMed · Cited by 393
Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marm�, D., & Gastl, G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<178::aid-cncr25>3.0.co;2-7 · Cited by 372
Vascular endothelial growth factor expression in early stage ovarian carcinoma
Paley, P. J., Staskus, K. A., Gebhard, K., Mohanraj, D., Twiggs, L. B., Carson, L. F., & Ramakrishnan, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970701)80:1<98::aid-cncr13>3.0.co;2-a · Cited by 364
Takebayashi, Y., Akiyama, S.-I., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F., & Aikou, T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1110 · Cited by 363
Toi, M., Inada, K., Suzuki, H., & Tominaga, T. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666040 · Cited by 362
Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., & Mori, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.537 · Cited by 356
Yamanaka, Y., Frieß, H., Büchler, M. W., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., & Korc, M. (1993) · PubMed · Cited by 354
Ishigami, S.-I., Arii, S., Furutani, M., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., & Imamura, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.688 · Cited by 338
Fibroblast growth factor: Structural and biological properties
Gospodarowicz, D., Neufeld, G., & Schweigerer, L. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330405 · Cited by 330
El-Assal, O. N., Yamanoi, A., Soda, Y., Yamaguchi, M., Igarashi, M., Yamamoto, A., Nabika, T., & Nagasue, N. (1998) · Hepatology · doi:10.1002/hep.510270613 · Cited by 326
Takahashi, Y. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430290087018 · Cited by 326
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717 · Cited by 319
Prognostic significance of angiogenesis in human pancreatic cancer
Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690248 · Cited by 316
Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., et al. (1996) · Hepatology · doi:10.1002/hep.510230309 · Cited by 307
Fontanini, G., Vignati, S., Boldrini, L., Chinè, S., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C. A., & Bevilacqua, G. (1997) · PubMed · Cited by 306
(2000) · PubMed · Cited by 304
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717.423k09_3717_3721 · Cited by 299
Platelet-Derived Growth Factor is Angiogenic In Vivo
Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., & Heldin, C.-H. (1992) · Growth Factors · doi:10.3109/08977199209046408 · Cited by 283
Giri, D., Ropiquet, F., & Ittmann, M. (1999) · PubMed · Cited by 280
Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.164 · Cited by 277
Dirix, L., Vermeulen, P., Pawinski, A., Prové, A., Benoy, I., De Pooter, C., Martin, M., & Van Oosterom, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.368 · Cited by 272
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
Linderholm, B., Tavelin, B., Grankvist, K., & Henriksson, R. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3121 · Cited by 264
Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., & Kozai, Y. (1991) · PubMed · Cited by 262
Linderholm, B., Grankvist, K., Wilking, N., Johansson, M., Tavelin, B., & Henriksson, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1423 · Cited by 254
Salvén, P., Orpana, A., & Joensuu, H. (1999) · PubMed · Cited by 252
Smith, B. D., Smith, G. L., Carter, D., Sasaki, C. T., & Haffty, B. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2046 · Cited by 250
Salven, P., Teerenhovi, L., & Joensuu, H. (1997) · Blood · doi:10.1182/blood.v90.8.3167 · Cited by 249
Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., et al. (1996) · PubMed · Cited by 244
Poon, R. T.-P., Ng, I. O.-L., Lau, C., Zhu, L.-X., Yu, W.-C., Lo, C.-M., Fan, S.-T., & Wong, J. (2001) · Annals of Surgery · doi:10.1097/00000658-200102000-00012 · Cited by 240
Self-citationTakahashi, Y., Bucana, C. D., Liu, W., Yoneda, J., Kitadai, Y., Cleary, K. R., & Ellis, L. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1146 · Cited by 239
Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa
DVORAK, H. F., NAGY, J. A., BERSE, B., BROWN, L. F., YEO, K., YEO, T., DVORAK, A. M., VAN DE WATER, L., SIOUSAT, T. M., & SENGER, D. R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51603.x · Cited by 232
Volm, M., Koomägi, R., & Mattern, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<64::aid-ijc11>3.0.co;2-i · Cited by 230
Crew, J. P., O'Brien, T., Bradburn, M., Fuggle, S., Bicknell, R., Cranston, D., & Harris, A. L. (1998) · The Journal of Urology · doi:10.1097/00005392-199811000-00090 · Cited by 225
宮寺, 和. (1999) · Medical Entomology and Zoology · doi:10.11501/3154225 · Cited by 225
Eppenberger, U., Kueng, W., Schlaeppi, J. M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3129 · Cited by 218
Regulation of distinct steps of angiogenesis by different angiogenic molecules.
Kumar, R., Yoneda, J., Bucana, C. D., & Fidler, I. J. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.4.749 · Cited by 204
New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
(2000) · Advances in Cancer Research · doi:10.1016/s0065-230x(00)79001-4 · Cited by 193
Kondo, S., Asano, M., Matsuo, K., Ohmori, I., & Suzuki, H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90016-7 · Cited by 191
Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., & Harris, A. L. (1995) · The Journal of Pathology · doi:10.1002/path.1711760212 · Cited by 190
Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salvén, P., Mänpää, H., Orpana, A., Alitalo, K. K., & Joensuu, H. (1997) · PubMed · Cited by 188
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
Kumar, H., Heer, K., Lee, P. W. R., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J., & Monson, J. R. T. (1998) · PubMed · Cited by 187
Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells
Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D., & Wilson, E. (1993) · Blood · doi:10.1182/blood.v81.3.631.631 · Cited by 182
Torimura, T., Sata, M., Ueno, T., Kin, M., Tsuji, R., Suzaku, K., Hashimoto, O., Sugawara, H., & Tanikawa, K. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90205-2 · Cited by 176
Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K., & Kotani, Y. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00282-2 · Cited by 175
Griffiths, L. A., Dachs, G. U., Bicknell, R., Harris, A. L., & Stratford, I. J. (1997) · PubMed · Cited by 175
Tanigawa, N., Amaya, H., Matsumura, M., & Shimomatsuya, T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.826 · Cited by 172
Imoto, H., Osaki, T., Taga, S., Ohgami, A., Ichiyoshi, Y., & Yasumoto, K. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70398-8 · Cited by 171
Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Marck, E. V., & Dirix, L. Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690437 · Cited by 165
Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., & Esumi, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201201 · Cited by 161
Borre, M., Nerstrøm, B., & Overgaard, J. (2000) · PubMed · Cited by 160
Thrombocytes Are the Major Source for Soluble Vascular Endothelial Growth Factor in Peripheral Blood
Gunsilius, E., Petzer, A., Stockhammer, G., Nussbaumer, W., Schumacher, P., Clausen, J., & Gastl, G. (2000) · Oncology · doi:10.1159/000012095 · Cited by 160
Menzel, T., Rahman, Z., Calleja, E., White, K., Wilson, E., Wieder, R., & Gabrilove, J. (1996) · Blood · doi:10.1182/blood.v87.3.1056.bloodjournal8731056 · Cited by 158
Angiogenic growth factors and endostatin in non‐Hodgkin's lymphoma
Bertolini, F., Paolucci, M., Peccatori, F. A., Cinieri, S., Agazzi, A., Ferrucci, P. F., Cocorocchio, E., Goldhirsch, A., & Martinelli, G. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01547.x · Cited by 156
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1455::aid-cncr11>3.0.co;2-l · Cited by 155
Angiogenesis as a Predictor of Long-term Survival for Patients With Node-Negative Breast Cancer
Heimann, R., Ferguson, D. J. P., Powers, C., Recant, W. M., Weichselbaum, R. R., & Hellmän, S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.23.1764 · Cited by 154
Russo, C. L., Pellarin, M., Tingby, O., Bollen, A. W., Lamborn, K. R., Mohapatra, G., Collins, V. P., & Feuerstein, B. G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<316::aid-cncr16>3.0.co;2-t · Cited by 153
Strydom, D. J. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050210 · Cited by 153
Ito, N., Kawata, S., Tamura, S., Takaishi, K., Shirai, Y., Kiso, S., Yabuuchi, I., Matsuda, Y., Nishioka, M., & Tarui, S. (1991) · PubMed · Cited by 152
Vacca, A., Ribatti, D., Ruco, L., Giacchetta, F., Nico, B., Quondamatteo, F., Ria, R., Iurlaro, M., & Dammacco, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690154 · Cited by 148
ACTIVATED HUMAN NEUTROPHILS EXPRESS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Webb, N. J. A., Myers, C. R., Watson, C. J., Bottomley, M. J., & Brenchley, P. E. (1998) · Cytokine · doi:10.1006/cyto.1997.0297 · Cited by 145
Koukourakis, M., Giatromanolaki, A. N., O'Byrne, K. J., Comley, M., Whitehouse, R. M., Talbot, D., Gatter, K., & Harris, A. L. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.83 · Cited by 145
Dosquet, C., Coudert, M., Lepage, É., Cabané, J., & Richard, F. (1997) · PubMed · Cited by 139
Shim, K. S., Kim, K. H., Han, W. S., & Park, E. B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<554::aid-cncr6>3.0.co;2-x · Cited by 138
Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness.
Shimoyama, S., Gansauge, F., Gansauge, S., Negri, G., Oohara, T., & Beger, H. G. (1996) · PubMed · Cited by 137
Jin-no, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Doi, T., Endo, H., Yamashita, T., & Okada, Y. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050099 · Cited by 126
Salvén, P., Heikkilä, P., Anttonen, A. M., Kajanti, M., & Joensuu, H. (1997) · PubMed · Cited by 126
Verheul, H. M. W., Hoekman, K., Lupu, F., Broxterman, H. J., van der Valk, P., Kakkar, A. K., & Pinedo, H. M. (2000) · PubMed · Cited by 123
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
Chopra, V., Ding, T. V., & Hanningan, E. V. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01214669 · Cited by 117
Koukourakis, M., Giatromanolaki, A. N., Kakolyris, S., O'Byrne, K. J., Apostolikas, N., Skarlatos, J., Gatter, K., & Harris, A. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.280 · Cited by 116
Serum VEGF levels in women with a benign breast tumor or breast cancer
Salvén, P., Perhoniemi, V. J., Tykkä, H., Mäenpää, H. O., & Joensuu, H. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006178517505 · Cited by 114
Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
Eisma, R. J., Spiro, J. D., & Kreutzer, D. L. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00166-9 · Cited by 111
Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma
Fujimoto, K., Ichimori, Y., Kakizoe, T., Okajima, E., Sakamoto, H., Sugimura, T., & Terada, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81305-1 · Cited by 109
Maniwa, Y., Okada, M., Ishii, N., & Kiyooka, K. (1998) · CHEST Journal · doi:10.1378/chest.114.6.1668 · Cited by 109
Graeven, U., Andre, N., Achilles, E. G., et al. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050319 · Cited by 102
Chen, C., Cheng, W., Lee, C., Chen, T.-M., Kung, C.-C. S., Hsieh, F.-J., & Hsieh, C. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5418 · Cited by 101
Salvén, P., Teerenhovi, L. M., & Joensuu, H. (1999) · Blood · doi:10.1182/blood.v94.10.3334.422k18_3334_3339 · Cited by 100
Amaya, H., Tanigawa, N., Lu, C., Matsumura, M., Shimomatsuya, T., Horiuchi, T., & Muraoka, R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00280-2 · Cited by 99
Circulating Vascular Endothelial Growth Factor in Patients With Colorectal Cancer
Fujisaki, K., Mitsuyama, K., Toyonaga, A., Matsuo, K., & Tanikawa, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00054-3 · Cited by 94
Li, D., Bell, J., Brown, A., & Berry, C. L. (1994) · The Journal of Pathology · doi:10.1002/path.1711720203 · Cited by 94
Linder, C., Linder, S., Munck‐Wikland, E., & Strander, H. A. (1998) · PubMed · Cited by 91
Smith, K., Fox, S. B., Whitehouse, R., Taylor, M., Greenall, M. J., Clarke, J., & Harris, A. L. (1999) · Annals of Oncology · doi:10.1023/a:1008303614441 · Cited by 90
Kitadai, Y., Ellis, L. M., Tucker, S. L., Greene, G. F., Bucana, C. D., Cleary, K. R., Takahashi, Y., Tahara, E., & Fidler, I. J. (1996) · Europe PMC (PubMed Central) · Cited by 87
Wakisaka, N., Wen, Q.-H., Yoshizaki, T., Nishimura, T., Furukawa, M., Kawahara, E., & Nakanishi, I. (1999) · The Laryngoscope · doi:10.1097/00005537-199905000-00024 · Cited by 82
Volm, M., Koomägi, R., Mattern, J., & Stammler, G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00411-x · Cited by 80
Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama, S., Yamasaki, K., Kawahara, M., & Kaminishi, M. (1999) · PubMed · Cited by 79
Zhou, J., Tang, Z., Fan, J., Wu, Z.-Q., Li, X., Liu, Y., Liu, F., Sun, H., & Ye, S. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050009 · Cited by 74
Colomer, R., Aparicio, J., Montero, S., Guzmán, C., Larrodera, L., & Cortés-Funes, H. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.536 · Cited by 69
Dellacono, F. R., Spiro, J. D., Eisma, R. J., & Kreutzer, D. L. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00169-4 · Cited by 67
Ueki, T., Koji, T., Tamiya, S., Nakane, P. K., & Tsuneyoshi, M. (1995) · The Journal of Pathology · doi:10.1002/path.1711770405 · Cited by 61
Takao, S., Takebayashi, Y., Che, X., Shinchi, H., Natsugoe, S., Miyadera, K., Yamada, Y., Akiyama, S., & Aikou, T. (1998) · PubMed · Cited by 61
Angiogenin expression and prognosis in primary breast carcinoma.
Montero, S., Guzmán, C., Cortés-Funes, H., & Colomer, R. (1998) · PubMed · Cited by 59
Significance of angiogenesis in cancer therapy
McNamara, D. A., Harmey, J. H., Walsh, T. N., Redmond, H. P., & Bouchier‐Hayes, D. J. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00816.x · Cited by 57
Matsumura, M., Chiba, Y., Lu, C., Amaya, H., Shimomatsuya, T., Horiuchi, T., Muraoka, R., & Tanigawa, N. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00051-2 · Cited by 57
Takanami, I., Tanaka, F., Hashizume, T., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00620-6 · Cited by 55
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
Chopra, V., Dinh, T. V., & Hannigan, E. V. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050045 · Cited by 54
Nagaoka, H., Iino, Y., Takei, H., & Morishita, Y. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.3.449 · Cited by 50
Basic fibroblast growth factor secreted by an animal tumor is detectable in urine.
Soutter, A. D., Nguyen, M. T. N., Watanabe, H., & Folkman, J. (1993) · PubMed · Cited by 50
Gazzaniga, P., Gandini, O., Gradilone, A., Silvestri, I., Giuliani, L., Magnanti, M., Gallucci, M., Saccani, G., Frati, L., & Aglianò, A. M. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.6.1123 · Cited by 49
Mottaz, A. E., Markwalder, R. V., Fey, M. F., Klima, I., Merz, V. W., Thalmann, G. N., Ball, R. K., & Studer, U. E. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970601)31:4<223::aid-pros3>3.0.co;2-l · Cited by 32
Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
Hata, K., Kamikawa, T., Arao, S., Tashiro, H., Katabuchi, H., Okamura, H., Fujiwaki, R., Miyazaki, K., & Fukumoto, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690294 · Cited by 27
Jin-no, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Endo, H., Doi, T., Mandai, K., & Ishitsuka, H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980401)82:7<1260::aid-cncr8>3.0.co;2-j · Cited by 21
Shimada, M., Hasegawa, H., Rikimaru, T., Gion, T., Hamatsu, T., Yanashita, Y.-I., Shirabe, K., & Sugimachi, K. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00331-6 · Cited by 10
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Metadata
- Authors
- Poon, R. T.-P., Fan, S.-T., & Wong, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-02-15
- Volume
- 19
- Issue
- 4
- Pages
- 1207-1225
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1918337600
- Cited by
- 587
- References
- 135
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.